| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
9,283 |
8,672 |
$713K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,927 |
1,804 |
$280K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,054 |
944 |
$224K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,519 |
2,444 |
$214K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,834 |
1,768 |
$116K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
891 |
839 |
$106K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,176 |
2,116 |
$30K |
| 71046 |
Radiologic examination, chest; 2 views |
659 |
631 |
$29K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,492 |
1,438 |
$28K |
| 87428 |
|
879 |
866 |
$24K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
806 |
740 |
$22K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
666 |
197 |
$17K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
435 |
401 |
$17K |
| 80053 |
Comprehensive metabolic panel |
4,543 |
4,257 |
$17K |
| 80061 |
Lipid panel |
1,694 |
1,678 |
$15K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
15 |
15 |
$15K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,224 |
1,205 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
5,736 |
5,115 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,875 |
2,626 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
951 |
938 |
$6K |
| 80305 |
|
584 |
525 |
$5K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
509 |
466 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
56 |
54 |
$1K |
| 85027 |
|
656 |
615 |
$1K |
| 80306 |
|
280 |
241 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
343 |
306 |
$840.79 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
574 |
553 |
$823.34 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
37 |
27 |
$784.99 |
| 87077 |
|
439 |
420 |
$717.42 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
595 |
591 |
$646.37 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,672 |
1,555 |
$630.81 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
37 |
37 |
$628.59 |
| 81025 |
|
682 |
663 |
$284.45 |
| 87070 |
|
653 |
642 |
$266.14 |
| 81001 |
|
1,166 |
1,116 |
$261.08 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
16 |
16 |
$252.46 |
| 99001 |
|
41 |
32 |
$244.72 |
| 82607 |
|
31 |
30 |
$236.85 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
255 |
131 |
$191.69 |
| 87143 |
|
54 |
50 |
$170.10 |
| 85610 |
|
155 |
139 |
$141.43 |
| 81003 |
|
297 |
285 |
$101.51 |
| 83690 |
|
193 |
177 |
$82.54 |
| 84439 |
|
13 |
13 |
$78.43 |
| 87430 |
|
221 |
217 |
$62.05 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
32 |
27 |
$60.21 |
| 83605 |
|
171 |
161 |
$40.32 |
| 87807 |
|
41 |
40 |
$31.08 |
| 85007 |
|
60 |
57 |
$27.50 |
| 81002 |
|
100 |
92 |
$19.67 |
| 84484 |
|
12 |
12 |
$17.02 |
| 81000 |
|
195 |
188 |
$16.80 |
| 85730 |
|
39 |
37 |
$11.34 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,594 |
1,454 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
44 |
38 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
63 |
57 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
46 |
40 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
607 |
594 |
$0.00 |
| J3490 |
Unclassified drugs |
53 |
38 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
38 |
38 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
32 |
32 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
309 |
296 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
100 |
87 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
12 |
12 |
$0.00 |